Company Profile
Company Profile
Sheng Chang Pharmaceutical Company was founded in 1946. Sheng Chang started from a small traditional herbal medicine manufacturer in Taipei and expanded to a modernized herbal medicine factory in Zhonghe City. In 2000, Sheng Chang invested over NT$3 billion in Zhongli to establish a comprehensive manufacturing and research center for advanced development of Chinese herbal medicine. The new GMP manufacturing facility is approximately 60,000 square meters and is one of the largest Chinese herbal medicine factories in Taiwan. The modernized facility is equipped with state-of-the art manufacturing equipment from Germany as well as a comprehensive R&D facility and TAF approved laboratory. In 2018, Sheng Chang passed the PIC/S GMP Certification from Japan (PMDA).
HISTORY
-
1946Sheng Chang Pharmaceutical Company was founded.
-
1966Zhonghe factory was completed and initiated production of concentrated Chinese Herbal Medicine.
-
1969Published first Sheng Chang Quarterly Journal on Herbal Medicine.
-
1975Awarded medicinal importation permit from Japan’s Ministry of Welfare.
-
1986First manufacturer of Chinese medicine to comply with GMP Manufacturing Standards.
-
1994Passed GMP audit by Australia’s Therapeutic Goods Administration (TGA).
-
2002Received the Prize of National Medical Technology Research and Development for CMC (Chemical, Manufacture and Control) of Liu Wei Di Huang Wan (Rehmannia Six formula).
-
2003The fingerprint platform of Si Wu Tang (DangGui Four Combination) and its derivative formulas won the Prize of National Medical Technology Research and Development .
-
2004The fingerprint platform of Chinese herbal formulas won the Prize of National Medical Technology Research and Development.
-
2006Received certification of ISO 9001:2000 international standard quality management system.
-
2008Received TAF ISO/IEC 17025 laboratory certification.
Received accreditation certificate of foreign drug manufacturer from Japan’s Ministry of Health Labour and Welfare. -
2010Received TFDA Drug Cosmetic Certification.
-
2011Passed both TAF and TFDA on-site evaluation.
-
2012Received TFDA Food Hygiene Inspection Agency Certification.
Received “Commercially available Chinese Herbal Medicine Monitoring Plan (CCMP101-CP-102)” from Committee on Chinese Medicine and Pharmacy. -
2013Received TFDA Food Hygiene Inspection Agency and Drug Cosmetic Inspection Agency Certification.
Received accreditation certificate of foreign drug manufacturer from Japan’s Ministry of Health Labour and Welfare. -
2014Received “Commercially available Chinese Herbal Medicine Monitoring Plan (M02G3121)” from Ministry of Health and Welfare.
-
2016Passed TFDA on-site evaluation.
-
2018Passed the PIC/S GMP Certification from Japan PMDA.
-
2019Passed FDA on-site evaluation.
-
2020Received certification of ISO 9001:2015 international standard quality management system.
Passed tourism factory by the Ministry of Economic Affairs, R.O.C. evaluation. -
2021取得外銷許可證及國內緊急使用授權 (EUA) 臺灣清冠一號Covi Away (NRICM101)。
全國第一家通過衛生福利部三階段確效查核中藥廠。
榮獲衛生福利部中醫藥發展獎勵第一屆玉階獎「領航貢獻獎」之殊榮
